Kelly Qiao
Investor at B Capital
China
Overview
Work Experience
Investor and Board
2024 - Current
Investor and Observer
2023
Investor and Observer
2022
Investor and Observer
2022
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
Raised $247,000,000.00 from Lilly Asia Ventures, Ally Bridge Group, T. Rowe Price, Janus Henderson Investors, LYFE Capital, Logos Capital, Piper Heartland Healthcare Capital, LifeSci Venture Partners, Medicxi and Surveyor Capital.
Investor
2021
Investor
Investor
2021
Investor
Investor and Observer
2021
Investor
Investor and Observer
2021
Investor
Senior Principal
2021
B Capital Group is a venture capital firm that backs global entrepreneurs in the field of information technology.
Managing Director
2018 - 2020
1.PE investment -Cross-border PIPE in largest long-term care listed in Euronext -Medical imaging, health insurance, digital health, drug store, senior caring, speciality hospitals 2.Growth fund with leading Nasdaq- and HKEX- dual listed biotech -Fund raising, team recruiting, deal sourcing, management -Focusing on next-generation drug and medtech in I/O, CNS, and metabolic therapeutic areas 3.Post-management